NCT02013336 2022-03-31Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid TumorsSouth Plains Oncology ConsortiumPhase 1 Unknown30 enrolled